Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-01-20 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
CONNECTED TRANSACTION PROPOSED AMENDMENTS TO THE TERMS OF THE CONVERTIBLE BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding proposed amendments to the terms of its convertible bonds. It details changes such as conversion price adjustment, maturity date extension, and interest rate increase. The document references previous announcements and amendment agreements, discusses shareholder approvals required, and includes detailed shareholding structure changes. It is a regulatory announcement about financing terms and capital structure changes, specifically about convertible bonds and their amendments. It is not a full financial report, earnings release, or management discussion, nor is it a proxy or voting result announcement. The content fits best under Capital/Financing Update (CAP) as it concerns amendments to convertible bonds, a financing instrument, and related capital structure implications. The document length and detail confirm it is not a brief report publication announcement or a simple regulatory filing. Confidence is high given the detailed financing terms and amendment agreements discussed.
2021-01-20 English
INSIDE INFORMATION - UPDATE ON THE CONVERTIBLE BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement by Sinopharm Tech Holdings Limited regarding the status and update on its convertible bonds. It references specific regulatory rules (GEM Listing Rules) and provides detailed information about the convertible bonds, their maturity, potential default events, and ongoing discussions about refinancing. The content focuses on financing activities and capital structure changes related to convertible bonds. The document is about an update on convertible bonds, which fits the category of Capital/Financing Update (CAP). The document length is 5179 characters, which is sufficient to contain substantive information rather than just a brief notice or report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2021-01-18 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including details about board committees and their members. It does not contain financial data, audit results, or report content. It is an announcement related to board composition and governance structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board information, confirming this classification.
2021-01-07 English
RE-DESIGNATION OF EXECUTIVE DIRECTOR AND CHAIRPERSON OF THE BOARD AND CHANGE IN COMPOSITION OF NOMINATION COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding changes in the company's board of directors and senior management roles, specifically the re-designation of an executive director and chairperson and changes in the nomination committee composition. It includes detailed biographical information about the individuals involved, their roles, shareholdings, and compliance with listing rules. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about changes in board or management personnel.
2021-01-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/12/2020. The content focuses on share capital changes, share options, warrants, and convertible bonds, with no financial statements or earnings data. This type of document is a regulatory filing reporting share capital movements and related securities information to the exchange, consistent with a Major Shareholding Notification or Share Issue/Capital Change. However, since it reports monthly movements in securities and share capital, it aligns best with Share Issue/Capital Change (SHA) filings, which cover announcements regarding new share issues, stock splits, or other capital changes. The document is detailed and substantive, not a brief announcement or certification, so it is not RNS or RPA. Therefore, the correct classification is SHA.
2021-01-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 30/11/2020. The content focuses on share capital changes, share options, warrants, and convertible bonds, with no financial performance data, earnings, or management discussion. It is a regulatory filing reporting share capital movements and related confirmations, typical of a Major Shareholding Notification or Share Issue/Capital Change. However, since it reports monthly movements in securities and share capital, it aligns best with Share Issue/Capital Change filings rather than Major Shareholding Notification which is about ownership thresholds. The document is detailed and substantive, not a brief announcement or certification, so it is not Regulatory Filings (RNS). Therefore, the most appropriate classification is Share Issue/Capital Change (SHA).
2020-12-04 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.